{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:02:16Z","timestamp":1778508136532,"version":"3.51.4"},"reference-count":52,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chronic obstructive pulmonary disease (COPD) is a preventable, treatable disease with significant extrapulmonary manifestations that could affect negatively its course in some patients. Hepatitis C virus infection (HCV), on the other hand, is associated with a number of extrahepatic manifestations. COPD patients have increased prevalence of HCV and patients with HCV, especially older ones, have increased prevalence and faster progression of COPD. HCV infection exerts long-term effects on lung tissue and is an additional risk factor for the development of COPD. The presence of HCV is associated with an accelerated loss of lung function in COPD patients, especially in current smokers. COPD could represent extrahepatic manifestation associated with HCV infection. The aim of this article was to review the literature on prevalence of HCV in COPD and vice versa, pathogenetic link and the consequences of their mutual existence.<\/jats:p>","DOI":"10.1515\/folmed-2017-0018","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T10:02:24Z","timestamp":1499940144000},"page":"132-138","source":"Crossref","is-referenced-by-count":4,"title":["Chronic Obstructive Pulmonary Disease and Hepatitis C"],"prefix":"10.1515","volume":"59","author":[{"given":"Evgeni V.","family":"Mekov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosen E.","family":"Petkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitar T.","family":"Kostadinov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krasimir A.","family":"Antonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deian T.","family":"Jelev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","reference":[{"key":"ref131","first-page":"370","article-title":"International variation in the prevalence of COPD ( the BOLD study ) : a population - based prevalence study","volume":"50","author":"Buist","year":"2007","journal-title":"Lancet"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"521","DOI":"10.7326\/0003-4819-122-7-199504010-00008","article-title":"The hepatopulmonary syndrome","volume":"122","author":"Lange","year":"1995","journal-title":"Ann Intern Med"},{"key":"ref261","first-page":"164","article-title":"Remodeling in asthma and chronic obstructive lung disease","volume":"38","author":"Jeffery","year":"2001","journal-title":"Am Respir Crit Care Med"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.2169\/internalmedicine.49.3948","article-title":"High COPD prevalence in patients with liver disease","volume":"49","author":"Minakata","year":"2010","journal-title":"Internal Medicine"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2169\/internalmedicine.40.1109","article-title":"Polymyositis , pulmonary fibrosis and malignant lymphoma associated with hepatitis C virus infection","volume":"40","author":"Aisa","year":"2001","journal-title":"Intern Med"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/thx.52.1.33","article-title":"Analysis of bronchoalveolar lavage fluid in patients with chronic hepatitis C before and after treatment with interferon","volume":"52","author":"Yamaguchi","year":"1997","journal-title":"Thorax"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1378\/chest.124.1.406","article-title":"Abi Pegylated interferon and ribavirin - induced interstitial pneumonitis with ARDS","volume":"124","author":"Nassif","year":"2003","journal-title":"Chest"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00004728-200303000-00030","article-title":"AN Interferon - induced sarcoidosis","volume":"27","author":"Rubinowitz","year":"2003","journal-title":"Comput Assist Tomogr"},{"key":"ref91","first-page":"39","article-title":"Hepatitis C virus infection and chronic obstructive pulmonary disease","volume":"9","author":"Erol","year":"2009","journal-title":"Hepatitis Monthly"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0168-8278(96)80113-9","article-title":"Side effects of high - dose interferon therapy for chronic hepatitis C","volume":"25","author":"Okanoue","year":"1996","journal-title":"J Hepatol"},{"key":"ref411","first-page":"138","article-title":"Comorbidities in older patients with HIV : a retrospective study","author":"Magalhaes","year":"2007","journal-title":"J Am Dent Assoc"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1183\/09031936.98.11051153","article-title":"Pulmonary vascular disorders in portal hypertension","volume":"11","author":"Herve","year":"1998","journal-title":"Eur Respir J"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0016-5085(91)90225-A","article-title":"Pulmonary hypertension complicating portal hypertension : prevalence and relation to splanchnic hemodynamics","volume":"100","author":"Hadengue","year":"1991","journal-title":"Gastroenterology"},{"key":"ref511","first-page":"321","article-title":"Treatment of chronic hepatitis C with recombinant interferon : a multicenter randomized , controlled trial Hepatitis Interventional Therapy Group","volume":"6","author":"Davis","year":"1989","journal-title":"Engl J Med"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/thx.51.3.312","article-title":"Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection","volume":"51","author":"Kubo","year":"1996","journal-title":"Thorax"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1513\/AnnalsATS.201405-225OC","article-title":"Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus - hepatitis C virus coinfection","volume":"11","author":"Sangal","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"6209","DOI":"10.1128\/JVI.75.13.6209-6211.2001","article-title":"Elevated levels of interleukin - in serum are associated with hepatitis C virus infection and resistance to interferon therapy","volume":"8","author":"Polyak","year":"2001","journal-title":"J Virol"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jmv.2108","article-title":"Bronchoalveolar lavage fluid analysis in individuals with chronic hepatitis C","volume":"66","author":"Idilman","year":"2002","journal-title":"J Med Virol"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1465-9921-12-117","article-title":"Interactions between HIV infection and chronic obstructive pulmonary disease : Clinical and epidemiological aspects","volume":"12","author":"Raynaud","year":"2011","journal-title":"Respiratory Research"},{"key":"ref551","first-page":"1431","article-title":"Pleural effusion during interferon treatment for chronic hepatitis C","volume":"47","author":"Takeda","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1165\/rcmb.4820","article-title":"Gene expression and immunolocalization of - lipoxygenase isozymes in the airway mucosa of smokers with chronic bronchitis","volume":"15","author":"Zhu","year":"2002","journal-title":"Am Respir Cell Mol Biol"},{"key":"ref561","first-page":"1905","article-title":"[ Interstitial pneumonia induced by interferon therapy in type C hepatitis Japanese","volume":"52","author":"Karino","year":"1994","journal-title":"Nippon Rinsho"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1111\/j.1365-2893.2007.00885.x","article-title":"Co - morbid medical and psychiatric illness and substance abuse in HCV - infected and uninfected veterans","volume":"14","author":"Butt","year":"2007","journal-title":"Viral Hepat"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1513\/pats.200504-026SR","article-title":"Systemic effects of chronic obstructive pulmonary disease","volume":"2","author":"Agusti","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1183\/09031936.04.00010904","article-title":"Pulmonary - hepatic vascular disorders PHD )","volume":"24","author":"Rodriguez","year":"2004","journal-title":"Eur Respir J"},{"key":"ref441","first-page":"309","article-title":"Liver and lung : hepatopulmonary syndrome","volume":"17","author":"Yen","year":"2002","journal-title":"Crit Illness"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2000-9506","article-title":"Epidemiology of hepatitis C : geographic differences and temporal trends","volume":"20","author":"Wasley","year":"2000","journal-title":"Semin Liver Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"020415","DOI":"10.7189\/jogh.05.020415","article-title":"Global and regional estimates of COPD prevalence : systematic review and meta - analysis","volume":"5","author":"Adeloye","year":"2015","journal-title":"Glob Health"},{"key":"ref371","first-page":"8","article-title":"CD T lymphocytes in viral hyperreactivity and muscarinic receptor dysfunction","volume":"6","author":"Adamko","year":"2003","journal-title":"Am Respir Crit Care Med"},{"key":"ref111","first-page":"63","article-title":"The impact and effect of liver insufficiency of HCV infection on patients with chronic obstructive pulmonary diseases Egyptian Journal of Chest Diseases and","volume":"5","author":"El","year":"2014","journal-title":"Tuberculosis"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s10620-007-0100-2","article-title":"The relationship between severity of liver cirrhosis and pulmonary function tests","volume":"53","author":"Yigit","year":"2008","journal-title":"Dig Dis Sci"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/JVI.01411-06","article-title":"Regulation of CXCL interleukin induction by double - stranded RNA signaling pathways during hepatitis C virus infection","volume":"8","author":"Wagoner","year":"2007","journal-title":"J Virol"},{"key":"ref191","doi-asserted-by":"crossref","DOI":"10.3109\/15412555.2013.800854","article-title":"Hepatitis C virus infection is not an independent risk factor for obstructive lung disease","volume":"11","author":"Fischer","year":"2014","journal-title":"COPD"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1386-6346(02)00136-5","article-title":"Clinical significance of intrahepatic interleukin - in chronic hepatitis C patients","volume":"24","author":"Mahmood","year":"2002","journal-title":"Hepatol Res"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1378\/chest.123.2.596","article-title":"Accelerated decline of lung function in COPD patients with chronic hepatitis C virus infection : a preliminary study based on small numbers of patients","volume":"123","author":"Kanazawa","year":"2003","journal-title":"Chest"},{"key":"ref401","first-page":"134","article-title":"Changing global epidemiology of pulmonary manifestations of HIV \/ AIDS","volume":"98","author":"Hull","year":"2008","journal-title":"Chest"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1023\/A:1018818801824","article-title":"Increased levels of soluble adhesion molecules in the serum of patients with hepatitis C : correlation with cytokine concentrations and liver inflammation and fibrosis","volume":"42","author":"Kaplanski","year":"1997","journal-title":"Dig Dis Sci"},{"key":"ref361","first-page":"167","article-title":"Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease","volume":"24","author":"Fabbri","year":"2003","journal-title":"Am Respir Crit Care Med"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/COPD.S40123","article-title":"Prevalence of renal and hepatobiliary disease , laboratory abnormalities , and potentially toxic medication exposures among persons with COPD Obstruct","volume":"8","author":"Mapel","year":"2013","journal-title":"Int J Chron Pulmon Dis"},{"key":"ref11","article-title":"COPD morbidity among smokers an epidemiological study","volume":"3","author":"Pavlov","year":"2011","journal-title":"Thoracic medicine"},{"key":"ref351","first-page":"160","article-title":"In vivo effector function of influenza virus - specific cytotoxic T lymphocyte clones is highly specific","volume":"26","author":"Lukacher","year":"1984","journal-title":"J Exp Med"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2169\/internalmedicine.47.0489","article-title":"Prevalence of COPD in primary care clinics : correlation with non - respiratory diseases","volume":"47","author":"Minakata","year":"2008","journal-title":"Internal Medicine"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1378\/chest.128.4.2882","article-title":"Hepatitis C virus and the lung : implications for therapy","volume":"128","author":"Moorman","year":"2005","journal-title":"Chest"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.dld.2006.06.008","article-title":"Extrahepatic manifestations of hepatitis C virus infection : a general overview and guidelines for a clinical approach","volume":"39","author":"Zignego","year":"2007","journal-title":"Dig Liver Dis"},{"key":"ref421","first-page":"358","article-title":"Hepatopulmonary syndrome a liver - induced lung vascular disorder","volume":"87","author":"Rodriguez","year":"2008","journal-title":"Engl J Med"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1378\/chest.112.4.980","article-title":"Distinctive clinical features of portopulmonary hypertension","volume":"112","author":"Kuo","year":"1997","journal-title":"Chest"},{"key":"ref221","first-page":"190","article-title":"de van Monocyte chemoattractant protein interleukin and chronic airways inflammation in COPD","volume":"1","author":"Boer","year":"2000","journal-title":"J Pathol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Mohd Global epidemiology of hepatitis C virus infection : new estimates of age - specific antibody to HCV seroprevalence","volume":"57","author":"Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S0950268809990276","article-title":"Prevalence of hepatitis C virus infection in patients with COPD","volume":"138","author":"Silva","year":"2010","journal-title":"Epidemiol Infect"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s002770100298","article-title":"Pulmonary artery hypertension during interferon therapy for chronic myelogenous leukemia","volume":"80","author":"Fruehauf","year":"2001","journal-title":"Ann Hematol"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.dld.2006.05.013","article-title":"Pulmonary alterations in patients with chronic HCV infection","volume":"38","author":"Erturk","year":"2006","journal-title":"Dig Liver Dis"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1172\/JCI1114","article-title":"Virus - and interferon - induced loss of inhibitory muscarinic receptor function and gene expression in cultured airway parasympathetic neurons","volume":"102","author":"Jacoby","year":"1998","journal-title":"J Clin Invest"}],"container-title":["Folia Medica"],"original-title":[],"link":[{"URL":"http:\/\/content.sciendo.com\/view\/journals\/folmed\/59\/2\/article-p132.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.degruyter.com\/view\/j\/folmed.2017.59.issue-2\/folmed-2017-0018\/folmed-2017-0018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T12:57:41Z","timestamp":1719320261000},"score":1,"resource":{"primary":{"URL":"http:\/\/archive.sciendo.com\/FOLMED\/folmed.2017.59.issue-2\/folmed-2017-0018\/folmed-2017-0018.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,1]]},"references-count":52,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1515\/folmed-2017-0018","relation":{},"ISSN":["1314-2143"],"issn-type":[{"value":"1314-2143","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,1]]}}}